Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Eger

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Pharmazie in Unserer Zeit|March 1, 1989
[Feasibility of isolating and purifying thymidine kinases with the use of affinity chromatography]K Eger, G Folkers, R Beck
Development, Growth & Differentiation|June 7, 2023
Possible involvement of an acylation mechanism in thalidomide-induced teratogenesis of the newt (Pleurodeles waltl.)C O Audit, K Eger, C Aimar
Journal of Medicinal Chemistry|September 16, 1994
Synthesis of new acyclic pyrimidine nucleoside analogs as potential antiviral drugsK Eger, E M Klünder, M Schmidt
Archiv Der Pharmazie|July 1, 1976
[Pyrrolo (2,3-B)pyridine]W Zimmermann, K Eger, H J Roth
Biochemical Pharmacology|October 1, 1988
7-Deaza-9-phenyladenines. A new class of adenosine receptor antagonistsJ W Daly, W L Padgett, K Eger
Archiv Der Pharmazie|March 21, 1998
5'-Substituted thalidomide analogs as modulators of TNF-alphaU Teubert, K Zwingenberger, S Wnendt, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 31, 2001
Profiling indomethacin impurities using high-performance liquid chromatography and nuclear magnetic resonanceS Hess, U Teubert, J Ortwein, et al.
Bone Marrow Transplantation|January 1, 1993
Thalidomide--the need for a new clinical evaluation of an old drugG Ehninger, K Eger, A Stuhler, et al.
Health Communication|January 12, 2024
LGBTQ+ Peer Advocates' Health Communication Praxis for College Student Health Outreach and Intersectional NeedsElizabeth K Eger, Melinda M Villagran, Marsha Burney
Der Nervenarzt|January 24, 1998
[Proximal myotonic myopathy (PROMM). Clinical variability within a family]K Eger, W J Schulte-Mattler, S Zierz
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Pharmazie in Unserer Zeit|March 1, 1989
[Feasibility of isolating and purifying thymidine kinases with the use of affinity chromatography]K Eger, G Folkers, R Beck
Development, Growth & Differentiation|June 7, 2023
Possible involvement of an acylation mechanism in thalidomide-induced teratogenesis of the newt (Pleurodeles waltl.)C O Audit, K Eger, C Aimar
Journal of Medicinal Chemistry|September 16, 1994
Synthesis of new acyclic pyrimidine nucleoside analogs as potential antiviral drugsK Eger, E M Klünder, M Schmidt
Archiv Der Pharmazie|July 1, 1976
[Pyrrolo (2,3-B)pyridine]W Zimmermann, K Eger, H J Roth
Biochemical Pharmacology|October 1, 1988
7-Deaza-9-phenyladenines. A new class of adenosine receptor antagonistsJ W Daly, W L Padgett, K Eger
Archiv Der Pharmazie|March 21, 1998
5'-Substituted thalidomide analogs as modulators of TNF-alphaU Teubert, K Zwingenberger, S Wnendt, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 31, 2001
Profiling indomethacin impurities using high-performance liquid chromatography and nuclear magnetic resonanceS Hess, U Teubert, J Ortwein, et al.
Bone Marrow Transplantation|January 1, 1993
Thalidomide--the need for a new clinical evaluation of an old drugG Ehninger, K Eger, A Stuhler, et al.
Health Communication|January 12, 2024
LGBTQ+ Peer Advocates' Health Communication Praxis for College Student Health Outreach and Intersectional NeedsElizabeth K Eger, Melinda M Villagran, Marsha Burney
Der Nervenarzt|January 24, 1998
[Proximal myotonic myopathy (PROMM). Clinical variability within a family]K Eger, W J Schulte-Mattler, S Zierz
Pageof 6